|Articles|September 8, 2011

Tricuspid Regurgitation

Description of image: Endovaginal ultrasound of a 12 week fetus revealing tricuspid regurgitation

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe

Related Content

Image credit: Society of Family Planning

Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal

ByJoshua Fitch, Senior Editor

September 10th 2026

Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo

ByJoshua Fitch, Senior Editor

September 10th 2026

PMOS Awareness Month: Watch our expert panel discussion on PMOS

ByJoshua Fitch, Senior Editor

September 9th 2026

Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling

ByKevin Ault, MD

September 9th 2026

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

ByJoshua Fitch, Senior Editor

September 9th 2026

Latest CME

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 4-5, 2026

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Tricuspid Regurgitation

Related Content

Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal

Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo

PMOS Awareness Month: Watch our expert panel discussion on PMOS

Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

Latest CME

Join Us at The Pathology Meeting in Las Vegas

Join Us at The Pathology Meeting in Las Vegas

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Trending on Contemporary OB/GYN

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

PMOS Awareness Month: Watch our expert panel discussion on PMOS

Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo

Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling

Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal